U.S. funding research of better anthrax vaccine | Bioethics and Ebola | Two Ebola vaccines shown safe as next step pondered | Why the CDC was blasted over lab safety violations | Veterans hurt by chemical weapons in Iraq get an apology | Why NIH’s Anthony Fauci is treating Ebola patients himself | New pandemic insurance to prevent crises through early payouts | Battle over science funding gets fiercer in Congress | K-State lab jump-starts NBAF research | Ebola more deadly for young children | U.S. developing bird flu vaccine, no distribution plans yet | Safer anthrax test aims to keep the bioweapon from terrorists | Scientists argue over access to remaining Ebola hotspots | Can a new White House plan catch up to the “superbug” threat? | Tuberculosis in the US: The good, the bad and the ugly | Guinea starts testing Merck vaccine in Ebola hotspots | The Biological Weapons Convention at forty | Development of candidate vaccine viruses for pandemic preparedness | Ebola response: Detecting the disease | Superslick coatings conquer ketchup, but what About Ebola? | Worldwide biosurveillance network still a distant goal | Ebola vaccines appear safe and successful, say US researchers | Catching Ebola: Mistakes, messages and madness | USDA at work on poultry vaccine for H5N8, H5N2 | British Ebola patient cured after experimental treatment | What’s up with parents who don’t vaccinate their children? | A necklace fit for a virus
See what we’re reading this week at Global Biodefense on topics like development of new anthrax vaccines, CDC lab safety violations, science funding and Congress and more…
U.S. funding research of better anthrax vaccine (Reuters)
Bioethics and Ebola (Bifurcated Needle)
Two Ebola vaccines shown safe as next step pondered (CIDRAP)
Why the CDC was blasted over lab safety violations (Nature)
Veterans hurt by chemical weapons in Iraq get an apology (NY Times)
Why NIH’s Anthony Fauci is treating Ebola patients himself (Science)
New pandemic insurance to prevent crises through early payouts (Reuters)
Battle over science funding gets fiercer in Congress (Scientific American)
K-State lab jump-starts NBAF research (Pork Network)
Ebola more deadly for young children (Imperial College)
U.S. developing bird flu vaccine, no distribution plans yet (Reuters)
Safer anthrax test aims to keep the bioweapon from terrorists (NPR)
Scientists argue over access to remaining Ebola hotspots (Science)
Can a new White House plan catch up to the “superbug” threat? (Frontline)
Tuberculosis in the US: The good, the bad and the ugly (Bifurcated Needle)
Guinea starts testing Merck vaccine in Ebola hotspots (Reuters)
The Biological Weapons Convention at forty (Department of State)
Development of candidate vaccine viruses for pandemic preparedness (Avian Flu Diary)
Ebola response: Detecting the disease (Tactical Defense Media)
Superslick coatings conquer ketchup, but what About Ebola? (NPR)
Worldwide biosurveillance network still a distant goal (National Defense)
Ebola vaccines appear safe and successful, say US researchers (Deutsche Welle)
Catching Ebola: Mistakes, messages and madness (Virology Down Under)
USDA at work on poultry vaccine for H5N8, H5N2 (CIDRAP)
British Ebola patient cured after experimental treatment (Reuters)
What’s up with parents who don’t vaccinate their children? (NPR)
A necklace fit for a virus (Science)
